SP
Therapeutic Areas
Axena Health Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Leva Pelvic Health System | Urinary Incontinence (UI) & Fecal Incontinence (FI) | Commercial |
| Real-World Evidence (RWE) Generation | UI & FI (Post-Market) | NA |
| Access Expansion (e.g., VA) | UI & FI | Commercial |
| International Feasibility (Nigeria Study) | UI | Feasibility |